We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$374M
AUM Growth
+$42.8M
Cap. Flow
+$17.1M
Cap. Flow %
4.58%
Top 10 Hldgs %
35.22%
Holding
192
New
13
Increased
44
Reduced
92
Closed
21
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JHSC icon
176
John Hancock Multifactor Small Cap ETF
JHSC
$744M
-40,497
Closed -$1.48M
MLCO icon
177
Melco Resorts & Entertainment
MLCO
$2.14B
-13,355
Closed -$118K
ONCY
178
Oncolytics Biotech
ONCY
$95.8M
-22,015
Closed -$29.7K
OVID icon
179
Ovid Therapeutics
OVID
$491M
-16,522
Closed -$53.2K
SKIN icon
180
SkinHealth Systems
SKIN
$85.7M
-41,144
Closed -$128K
SNDL icon
181
Sundial Growers
SNDL
$320M
-44,420
Closed -$72.8K
SOFI icon
182
SoFi Technologies
SOFI
$23.7B
-15,223
Closed -$151K
TLRY icon
183
Tilray
TLRY
$622M
-1,315
Closed -$30.2K
TOTL icon
184
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
-13,279
Closed -$534K
TSLA icon
185
Tesla
TSLA
$1.3T
-958
Closed -$238K
UPS icon
186
United Parcel Service
UPS
$88.9B
-1,536
Closed -$241K
VWO icon
187
Vanguard FTSE Emerging Markets ETF
VWO
$124B
-7,637
Closed -$314K
ZYXI
188
DELISTED
Zynex
ZYXI
-11,215
Closed -$122K
MIR.WS
189
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
-12,523
Closed -$25.4K
NVTA
190
DELISTED
Invitae Corporation
NVTA
-11,522
Closed -$7.22K
MDNA
191
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
-12,915
Closed -$3.94K

Similar funds

Newman Dignan & Sheerar Inc's Q1 2024 Portfolio in Review

As of Q1 2024, Newman Dignan & Sheerar Inc held 192 positions worth $374M, up 13% from $331M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Newman Dignan & Sheerar Inc deployed $17.1M of net new capital in Q1 2024, opening 13 new positions and adding to 44 existing holdings. Its largest new stake was Applied Finance Valuation Large Cap ETF: 525,714 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $2.21M trimmed.

  • Newman Dignan & Sheerar Inc's largest Q1 2024 buy was Applied Finance Valuation Large Cap ETF: 525,714 shares worth $17.1M.
  • Newman Dignan & Sheerar Inc added most to Dimensional Emerging Core Equity Market ETF in Q1 2024, an estimated $1.05M increase.
  • Newman Dignan & Sheerar Inc's biggest Q1 2024 reduction was iShares iBonds Dec 2024 Term Corporate ETF, cutting an estimated $2.21M.
  • Newman Dignan & Sheerar Inc fully exited John Hancock Multifactor Small Cap ETF in Q1 2024, selling an estimated $1.48M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 35% of its $374M portfolio in Q1 2024.
  • Newman Dignan & Sheerar Inc opened 13 new positions and closed 21 in Q1 2024.
  • Newman Dignan & Sheerar Inc's portfolio value rose 13% quarter-over-quarter to $374M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q1 2024, filed 29 Apr 2024.